Biological and genetic characterization of a human immunodeficiency virus strain resistant to CXCR4 antagonist T134

AIDS Research and Human Retroviruses

Volumn 17, Issue 7, 2001, Pages 615-622

  Kanbara, K ^a   Sato, S ^a   Tanuma, J I ^a   Tamamura, H ^b   Gotoh, K ^a   Yoshimori, M ^a   Kanamoto, T ^a   Kitano, M ^a   Fujii, N ^b   Nakashima, H ^a  

^a KAGOSHIMA UNIVERSITY   (Japan)

^b KYOTO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

1,1' [1,4 PHENYLENEBIS(METHYLENE)]BIS(1,4,8,11 TETRAAZACYCLOTETRADECANE); ALPHA N ACETYLNONA DEXTRO ARGININE AMIDE; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; CHEMOKINE RECEPTOR CCR5; CHEMOKINE RECEPTOR CXCR4; CURDLAN; GLYCOPROTEIN GP 120; LIGAND; MONOCYTE INFLAMMATORY PROTEIN 1ALPHA; MONOCYTE INFLAMMATORY PROTEIN II; N [4 [[[6,7 DIHYDRO 2 (4 METHYLPHENYL) 5H BENZOCYCLOHEPTEN 8 YL]CARBONYL]AMINO]BENZYL] N,N DIMETHYL 2H TETRAHYDROPYRAN 4 AMINIUM CHLORIDE; POLYPEPTIDE; PROTEIN; RANTES; STROMAL CELL DERIVED FACTOR 1; SYNTHETIC PEPTIDE; T 134; T 140; T 22; UNCLASSIFIED DRUG; ZIDOVUDINE;

ANIMAL CELL; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CROSS RESISTANCE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LYMPHOID CELL; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN DOMAIN; VIRUS MUTATION; VIRUS REPLICATION; VIRUS STRAIN;

AMINO ACID SEQUENCE; ANTI-HIV AGENTS; BASE SEQUENCE; CELLS, CULTURED; DRUG RESISTANCE; HIV INFECTIONS; HIV-1; MOLECULAR SEQUENCE DATA; OLIGOPEPTIDES; RECEPTORS, CCR5; RECEPTORS, CXCR4; VIRUS REPLICATION;

EID: 0034928930     PISSN: 08892229     EISSN: None     Source Type: Journal    
DOI: 10.1089/088922201300119716     Document Type: Article

References (46)

1. + T cells
2. Chemokines and HIV-1 second receptor
3. CC CKR5: A RANTES, MIP-1α, MIP-1β receptor as a fusion cofactor for macrophage-tropic HIV-1
4. The β-chemokine receptors CCR3 and CCR5 facilitate infection by primary HIV-1 isolates
5. Identification of a major coreceptor for primary isolates of HIV-1
6. A dual-tropic primary HIV-1 isolate that uses fusin and the β-chemokine receptors CKR-5, CKR-3, and CKR-2B as fusin cofactors
7. HIV-1 entry into CD4+ cells is mediated by the chemokine receptor CC-CKR-5
8. HIV-1 entry cofactor: Functional cDNA cloning of a seven-transmembrane, G protein-coupled receptor
9. Change in coreceptor use correlates with disease progression in HIV-1-infected individuals
10. Biological phenotype of human immunodeficiency virus type 1 clones at different stages of infection: Progression of disease is associated with a shift from monocytotropic to T-cell-tropic virus population
11. Changing virus-host interactions in the course of HIV-1 infection
12. T134, a small molecule CXCR4 inhibitor, has no cross-drug resistance with AMD3100, a CXCR4 antagonist with different structure
13. 7]-polyphemusin II)
14. Related articles marked increase in anti-HIV activity, as well as inhibitory activity against HIV entry mediated by CXCR4, linked to enhancement of the binding ability of tachyplesin analogs to CXCR4
15. The molecular target of bicyclams, potent inhibitors of human immunodeficiency virus replication
16. AMD3100, a small molecule inhibitor of HIV-1 entry via the CXCR4 co-receptor
17. Inhibition of T-tropic HIV strains by selective antagonization of the chemokine receptor CXCR4
18. A small-molecule inhibitor directed against the chemokine receptor CXCR4 prevents its use as an HIV-1 coreceptor
19. Antherpetic activities of N-α-acetyl-nona-D-arginine amide acetate
20. Angiogenic and HIV-inhibitory functions of KSHV-encoded chemokines
21. A broad-spectrum chemokine antagonist encoded by Kaposi's sarcoma-associated herpesvirus
22. Genetic correlates of in vivo viral resistance to indinavir, a human immunodeficiency virus type 1 protease inhibitor
23. In vivo emergence of HIV-1 variants resistant to multiple protease inhibitors
24. Mutational anatomy of an HIV-1 protease variant conferring cross-resistance to protease inhibitors in clinical trials. Compensatory modulations of binding and activity
25. Emergence of human immunodeficiency virus type 1 variants with resistance to multiple dideoxynucleosides in patients receiving therapy with dideoxynucleosides
26. Resistance to human immunodeficiency virus type 1 protease inhibitors
27. Human immunodeficiency virus glycoprotein gp120 as the primary target for the antiviral action of AR177 (Zintevir)
28. Development of resistance of human immunodeficiency virus type 1 to dextran sulfate associated with the emergence of specific mutations in the envelope gp120 glycoprotein
29. 3′-Azido-3′-deoxythymidine resistance suppressed by a mutation conferring human immunodeficiency virus type 1 resistance to nonnucleoside reverse transcriptase inhibitors
30. Characterization of human immunodeficiency virus type 1 resistant to modified cycrodextrin sulphate (mCDS71) in vitro
31. T-cell-line-tropic human immunodeficiency virus type 1 that is made resistant to stromal cell-derived factor 1α contains mutations in the envelope gp120 but does not show a switch in coreceptor use
32. CD4-dependent, antibody-sensitive interactions between HIV-1 and its co-receptor CCR-5
33. Macrophage tropism determinants of human immunodeficiency virus type 1 in vitro
34. A low molecular weight inhibitor against the chemokine receptor CXCR4: A strong anti-HIV peptide T140
35. A small molecule CXCR4 inhibitor that blocks T cell line-tropic HIV-1 infection
36. Anti-human immunodeficiency virus activity of a novel synthetic peptide, T22 ([Tyr-5,12, Lys-7]polyphemusin II): A possible inhibitor of virus-cell fusion
37. Unambiguous synthesis of stromal cell-derived factor-1 by regioselective disulfide bond formation using a DMSO-aqueous HCl system
38. Synthesis and structure-activity relationships of phenylenebis-(methylene)-linked bis-tetraazamacrocycles that inhibit HIV replication. Effects of macro-cyclic ring size and substituents on the aromatic linker
39. Detection of replication-competent and pseudotyped human immunodeficiency virus with a sensitive cell line on the basis of activation of an integrated β-galactosidase gene
40. Rapid and automated tetrazolium-based colorimetric assay for the detection of anti-HIV compounds
41. Macrophage and T-cell-line tropisms of HIV-1 are determined by specific regions of the envelope gp120 gene
42. Susceptibilities of human immunodeficiency virus type 1 enzyme and viral variants expressing multiple resistance-engendering amino acid substitutions to reverse transcriptase inhibitors
43. Convergent combination therapy can select viable multidrug-resistant HIV-1 in vitro
44. Macrophage tropism of human immunodeficiency virus type 1 and utilization of the CC-CKR5 coreceptor
45. Phenotype-associated sequence variation in the third variable domain of the human immunodeficiency virus type 1 gp120 molecule
46. Variable sensitivity of CCR5-tropic human immunodeficiency virus type 1 isolates to inhibition by RANTES analogs